139 related articles for article (PubMed ID: 35025137)
1. Anu taila, an herbal nasal drop, suppresses mucormycosis by regulating host TNF-α response and fungal ergosterol biosynthesis.
Balkrishna A; Rastogi S; Kharayat B; Tomer M; Varshney Y; Singh K; Kumari P; Dev R; Srivastava J; Haldar S; Varshney A
J Appl Microbiol; 2022 Apr; 132(4):3355-3374. PubMed ID: 35025137
[TBL] [Abstract][Full Text] [Related]
2. Anu Taila, an herbal nasal-drop, delays spore germination in Cunninghamella bertholletiae by reducing cAMP-PKA dependent ROS in mucorale pathogen and extrinsic ROS in human host cells.
Balkrishna A; Sengupta S; Kumari P; Dev R; Haldar S; Varshney A
Lett Appl Microbiol; 2023 Feb; 76(2):. PubMed ID: 36708174
[TBL] [Abstract][Full Text] [Related]
3. Rhinocerebral mucormycosis diagnosis by aspiration cytology.
Deshpande AH; Munshi MM
Diagn Cytopathol; 2000 Aug; 23(2):97-100. PubMed ID: 10888753
[TBL] [Abstract][Full Text] [Related]
4. Vacuum-Assisted Closure and Skin Grafting Combined with Amphotericin B for Successful Treatment of an Immunocompromised Patient with Cutaneous Mucormycosis Caused by Mucor irregularis: A Case Report and Literature Review.
Tang X; Guo P; Wong H; Xie J; Han J; Xu Y; Zhou H
Mycopathologia; 2021 Jun; 186(3):449-459. PubMed ID: 34131870
[TBL] [Abstract][Full Text] [Related]
5. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U
Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357
[TBL] [Abstract][Full Text] [Related]
6. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
[TBL] [Abstract][Full Text] [Related]
7. Drug-Resistant Epimutants Exhibit Organ-Specific Stability and Induction during Murine Infections Caused by the Human Fungal Pathogen Mucor circinelloides.
Chang Z; Heitman J
mBio; 2019 Nov; 10(6):. PubMed ID: 31690679
[TBL] [Abstract][Full Text] [Related]
8. Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the Mucor species complex.
Navarro-Mendoza MI; Pérez-Arques C; Parker J; Xu Z; Kelly S; Heitman J
bioRxiv; 2024 Jun; ():. PubMed ID: 38076934
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of a necrotizing fasciitis patient caused by Mucor indicus with amphotericin B and skin grafting.
Luo Y; Zeng F; Huang X; Li Q; Tan G; Xi L; Lu C; Guo Q
Mycopathologia; 2014 Apr; 177(3-4):187-92. PubMed ID: 24570041
[TBL] [Abstract][Full Text] [Related]
10. Nasal application of sesame oil-based Anu taila as 'biological mask' for respiratory health during COVID-19.
Vijay B; Diwan B; Devkumar P; Shankar P; Vishnuprasad CN; Singh G; Kataria D; Shankar D
J Ayurveda Integr Med; 2023; 14(5):100773. PubMed ID: 37660545
[TBL] [Abstract][Full Text] [Related]
11. Mucor irregularis infection around the inner canthus cured by amphotericin B: a case report and review of published literatures.
Kang D; Jiang X; Wan H; Ran Y; Hao D; Zhang C
Mycopathologia; 2014 Aug; 178(1-2):129-33. PubMed ID: 24947172
[TBL] [Abstract][Full Text] [Related]
12.
Pérez-Arques C; Navarro-Mendoza MI; Murcia L; Lax C; Martínez-García P; Heitman J; Nicolás FE; Garre V
mBio; 2019 Feb; 10(1):. PubMed ID: 30723131
[TBL] [Abstract][Full Text] [Related]
13. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
14. Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.
Antoniadi K; Iosifidis E; Vasileiou E; Tsipou C; Lialias I; Papakonstantinou E; Kattamis A; Polychronopoulou S; Roilides E; Tragiannidis A
J Pediatr Hematol Oncol; 2021 Jul; 43(5):176-179. PubMed ID: 32890077
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection.
Ben-Ami R; Lewis RE; Tarrand J; Leventakos K; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Jan; 54(1):484-90. PubMed ID: 19858263
[TBL] [Abstract][Full Text] [Related]
16. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.
Perkhofer S; Locher M; Cuenca-Estrella M; Rüchel R; Würzner R; Dierich MP; Lass-Flörl C
Antimicrob Agents Chemother; 2008 Jul; 52(7):2636-8. PubMed ID: 18458135
[TBL] [Abstract][Full Text] [Related]
17. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
Jantunen E; Kolho E; Ruutu P; Koukila-Kähkölä P; Virolainen M; Juvonen E; Volin L
Bone Marrow Transplant; 1996 Jul; 18(1):229-30. PubMed ID: 8832023
[TBL] [Abstract][Full Text] [Related]
18. Mucormycosis experience through the eyes of the laboratory.
Sağıroğlu P; Nedret Koç A; Atalay MA; Altinkanat Gelmez G; Canöz Ö; Mutlu Sarıgüzel F
Infect Dis (Lond); 2019 Oct; 51(10):730-737. PubMed ID: 31364897
[No Abstract] [Full Text] [Related]
19. Identification and estimation of bioactive constituents Negundoside, Berberine chloride, and Marmelosin by HPLC and HPTLC for development of quality control protocols for Ayurvedic medicated oil formulation.
Meena AK; Rekha P; Perumal A; Ilavarasan R; Singh R; Srikant N; Dhiman KS
Futur J Pharm Sci; 2021; 7(1):171. PubMed ID: 34466412
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of zygomycosis cases by pooled analysis method reported from Turkey].
Zeka AN; Taşbakan M; Pullukçu H; Sipahi OR; Yamazhan T; Arda B
Mikrobiyol Bul; 2013 Oct; 47(4):708-16. PubMed ID: 24237440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
